Document Detail


Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance.
MedLine Citation:
PMID:  23029189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present investigation was undertaken to test whether exercise training (ET) associated with AMPK/PPAR agonists (EM) would improve skeletal muscle function in mdx mice. These drugs have the potential to improve oxidative metabolism. This is of particular interest because oxidative muscle fibers are less affected in the course of the disease than glycolitic counterparts. Therefore, a cohort of 34 male congenic C57Bl/10J mdx mice included in this study was randomly assigned into four groups: vehicle solution (V), EM [AICAR (AMPK agonist, 50 mg/Kg-1.day-1, ip) and GW 1516 (PPARδ agonist, 2.5 mg/Kg-1.day-1, gavage)], ET (voluntary running on activity wheel) and EM+ET. Functional performance (grip meter and rotarod), aerobic capacity (running test), muscle histopathology, serum creatine kinase (CK), levels of ubiquitined proteins, oxidative metabolism protein expression (AMPK, PPAR, myoglobin and SCD) and intracellular calcium handling (DHPR, SERCA and NCX) protein expression were analyzed. Treatments started when the animals were two months old and were maintained for one month. A significant functional improvement (p<0.05) was observed in animals submitted to the combination of ET and EM. CK levels were decreased and the expression of proteins related to oxidative metabolism was increased in this group. There were no differences among the groups in the intracellular calcium handling protein expression. To our knowledge, this is the first study that tested the association of ET with EM in an experimental model of muscular dystrophy. Our results suggest that the association of ET and EM should be further tested as a potential therapeutic approach in muscular dystrophies.
Authors:
Carlos R Bueno Júnior; Lucas C Pantaleão; Vanessa A Voltarelli; Luiz Henrique M Bozi; Patricia Chakur Brum; Mayana Zatz
Related Documents :
12952269 - Bosentan treatment in patients with primary pulmonary hypertension receiving nonparente...
6807559 - Limitations to exercise capacity and endurance: pulmonary system.
7323489 - Interpretation of inert gas retention and excretion in the presence of stratified inhom...
3665399 - The transfer factor (diffusing capacity) as a predictor of hypoxaemia during exercise i...
3455549 - The acute haemodynamic effects of intravenous verapamil in patients with chronic obstru...
12010939 - Flow during exercise in the total cavopulmonary connection measured by magnetic resonan...
24149559 - Obesity-related cardiovascular risk factors after long- term resistance training and gi...
23922719 - Black tea high-molecular-weight polyphenol stimulates exercise training-induced improve...
9818159 - Does plasma l-arginine level play a role in regulation of blood pressure during exercis...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-09-21
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-02     Completed Date:  2013-03-28     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e45699     Citation Subset:  IM    
Affiliation:
Human Genome Research Center - Institute of Biosciences, University of Sao Paulo, Sao Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenylate Kinase / drug effects*
Adipose Tissue
Animals
Calcium / metabolism
Kidney Function Tests
Male
Mice
Mice, Inbred C57BL
Mice, Inbred mdx
Muscle Proteins / metabolism
Muscle, Skeletal / metabolism,  pathology
Oxidation-Reduction
Peroxisome Proliferator-Activated Receptors / agonists*
Physical Conditioning, Animal*
Chemical
Reg. No./Substance:
0/Muscle Proteins; 0/Peroxisome Proliferator-Activated Receptors; 7440-70-2/Calcium; EC 2.7.4.3/Adenylate Kinase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depend...
Next Document:  Mycobacterium tuberculosis infection and tissue factor expression in macrophages.